These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24694255)
1. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies. Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255 [TBL] [Abstract][Full Text] [Related]
2. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects. Xia S; Wu S; Wang M Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875 [TBL] [Abstract][Full Text] [Related]
3. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis. Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981 [TBL] [Abstract][Full Text] [Related]
4. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis. Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953 [TBL] [Abstract][Full Text] [Related]
5. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls. Zhuo W; Zhang L; Cai L; Zhu B; Chen Z Exp Biol Med (Maywood); 2013 Jan; 238(1):66-76. PubMed ID: 23479765 [TBL] [Abstract][Full Text] [Related]
6. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis. Liu DY; Liang HC; Xiao XM Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915 [TBL] [Abstract][Full Text] [Related]
7. Genetic Association between the XPG Asp1104His Polymorphism and Head and Neck Cancer Susceptibility: Evidence Based on a Meta-Analysis. Jiang HY; Zeng Y; Xu WD; Liu C; Wang YJ; Wang YD; Wang YD Asian Pac J Cancer Prev; 2015; 16(9):3645-51. PubMed ID: 25987016 [TBL] [Abstract][Full Text] [Related]
8. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects. Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility. Zhu W; Yao J; Li Y; Xu B Tumour Biol; 2014 Apr; 35(4):3061-6. PubMed ID: 24258108 [TBL] [Abstract][Full Text] [Related]
10. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population. Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925 [TBL] [Abstract][Full Text] [Related]
11. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210 [TBL] [Abstract][Full Text] [Related]
12. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis. Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739 [TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma. Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970 [TBL] [Abstract][Full Text] [Related]
14. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis. Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725 [TBL] [Abstract][Full Text] [Related]
15. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk. Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482 [TBL] [Abstract][Full Text] [Related]
16. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis. Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324 [TBL] [Abstract][Full Text] [Related]
17. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Wu K; Su D; Lin K; Luo J; Au WW Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363 [TBL] [Abstract][Full Text] [Related]
18. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis. Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722 [TBL] [Abstract][Full Text] [Related]
19. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis. Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575 [TBL] [Abstract][Full Text] [Related]
20. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis. Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]